Fundraising Fox
🦊/Companies
Sign in

Verinetics

Research Triangle Park, US · Founded 2011 · Delaware corporation · 1 known investors

Find your way into Verinetics

Healthtech

Founders & leadership

JS
Jessica S. BeaverinPresident & CEOJessica S. Beaver has over 20 years of pharmaceutical industry experience across R&D, regulatory strategy, and compliance, with a background in clinical pharmacology and translational medicine. She has held executive and regulatory leadership roles at multiple pharmaceutical and medical device companies, managing FDA interactions across therapeutic areas including CNS, rheumatology, oncology, and women's health.
PW
Petra Weishaupt-SmithExecutive
TJ
Thomas J. MercolinoNamed on SEC filing

Board

RV
Ron VeredBoard director
EE
Ed EricksonBoard director

Investors · 1

IDEA NCDurham · $250K – $2M

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 5 rounds · 2012–2025

▶$135KraisedMar 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas J. MercolinoExecutive Officer, Director
  • Jessica S. BeaverExecutive Officer
Offering amount
$1M
Amount sold
$135K
First sale
Mar 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedMar 2024 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jessica S. BeaverExecutive Officer
  • Thomas J. MercolinoExecutive Officer, Director
Offering amount
$750K
Amount sold
$150K
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$907.2KraisedApr 2023 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas J. MercolinoExecutive Officer, Director
  • Petra Weishaupt-SmithExecutive Officer
Offering amount
$1M
Amount sold
$907.2K
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$215KraisedSep 2015 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron VeredDirector
  • Petra Weishaupt-SmithExecutive Officer
  • Thomas J. MercolinoExecutive Officer, Director
Offering amount
$600K
Amount sold
$215K
First sale
May 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$625.8KraisedApr 2014 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Petra Weishaupt-SmithExecutive Officer
  • Thomas MercolinoExecutive Officer, Director
  • Ron VeredDirector
  • Ed EricksonDirector
Offering amount
$625.8K
Amount sold
$625.8K
First sale
Aug 2012
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Verinetics Secures $135K to Revolutionize Opioid Use Disorder Treatment with the DispenSecur™ System | SignalBasetrysignalbase.com · Apr 2025Venture Connect-bound Verinetics Tackling Opioid Crisis With Tech – GrepBeatgrepbeat.com · Mar 2024

Frequently asked questions

Who are Verinetics's investors?
Verinetics's investors include IDEA NC.
How much funding has Verinetics raised?
Verinetics has disclosed $2M raised across 5 rounds.
Where is Verinetics headquartered?
Verinetics is headquartered in Research Triangle Park, US.